Latest news
TG Therapeutics, Inc. (TGTX) Stock forecasts - Yahoo Finance UKYahoo Finance UK · Sun, 09 Aug 2026 06:22:33 GMTTG Therapeutics (TGTX) Is Down 7.4% After Q2 Profit Drop Despite Higher 2026 Revenue Guidance – Has The Bull Case Changed? - SahmSahm · Sat, 08 Aug 2026 18:38:48 GMTTGTX Stock Hits Fresh 52-Week High – Here’s Why Retail Is Bullish Despite Q1 Earnings Miss - StocktwitsStocktwits · Sat, 08 Aug 2026 02:18:44 GMTTG Therapeutics (TGTX) Looks Fairly Valued After Raised 2026 Guidance And Mixed Q2 Earnings - simplywall.stsimplywall.st · Thu, 06 Aug 2026 08:14:06 GMTTG Therapeutics Inc (TGTX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKeyTradingKey · Thu, 06 Aug 2026 07:00:00 GMTTG Therapeutics Earnings Call Signals BRIUMVI Surge - The Globe and MailThe Globe and Mail · Thu, 06 Aug 2026 01:06:00 GMTTG Therapeutics 2026: Revenue $240.34M, EPS $0.05— 10-Q Summary - TradingViewTradingView · Wed, 05 Aug 2026 21:02:08 GMTTG Therapeutics (NASDAQ: TGTX) grows 2026 revenue to $445 million - Stock TitanStock Titan · Wed, 05 Aug 2026 21:01:51 GMT